Target type: biologicalprocess
The process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure. [GOC:devbiol]
Erythrocyte development, also known as erythropoiesis, is a complex and tightly regulated process that begins in the bone marrow and culminates in the production of mature red blood cells (erythrocytes). These cells are essential for oxygen transport throughout the body. Here is a detailed description of the process:
1. **Commitment of Hematopoietic Stem Cells:** The journey begins with hematopoietic stem cells (HSCs), which are pluripotent cells capable of differentiating into various blood cell lineages. These cells are influenced by various growth factors and cytokines, including erythropoietin (EPO), to commit to the erythroid lineage.
2. **Proerythroblast Formation:** Committed progenitor cells undergo multiple rounds of cell division, ultimately giving rise to proerythroblasts. These cells are characterized by a large nucleus and a prominent nucleolus.
3. **Basophilic Erythroblast Stage:** As proerythroblasts mature, they progress to the basophilic erythroblast stage. At this point, ribosome synthesis is active, resulting in a high concentration of RNA within the cell, which imparts a basophilic staining pattern.
4. **Polychromatophilic Erythroblast Stage:** The next stage, the polychromatophilic erythroblast stage, is marked by the synthesis of hemoglobin, the protein responsible for oxygen transport. The cell's cytoplasm begins to exhibit a mixed basophilic and eosinophilic staining pattern due to the presence of both RNA and hemoglobin.
5. **Orthochromatophilic Erythroblast Stage:** As hemoglobin synthesis intensifies, the cytoplasm becomes predominantly eosinophilic in the orthochromatophilic erythroblast stage. The nucleus, which was previously large and prominent, begins to condense and shrink.
6. **Reticulocyte Stage:** In the reticulocyte stage, the nucleus is extruded from the cell, leaving behind a small amount of residual RNA. These cells are still capable of synthesizing hemoglobin and are released into the bloodstream.
7. **Mature Erythrocyte Formation:** Finally, the reticulocyte loses its remaining RNA and matures into a fully functional erythrocyte. Mature erythrocytes are biconcave discs devoid of a nucleus and organelles, allowing for maximum oxygen carrying capacity.
8. **Regulation by Erythropoietin:** Erythropoiesis is tightly regulated by the hormone erythropoietin (EPO), primarily produced by the kidneys. EPO levels are influenced by factors such as oxygen tension in the blood. Low oxygen levels trigger EPO production, stimulating erythropoiesis and increasing the number of red blood cells.
9. **Iron Requirement:** Erythrocyte development necessitates a sufficient supply of iron, which is incorporated into hemoglobin. Iron deficiency can lead to impaired erythropoiesis and anemia.
10. **Other Factors:** Vitamin B12 and folate are also essential for normal erythropoiesis. Deficiency in these nutrients can disrupt DNA synthesis and cell division, leading to megaloblastic anemia.
This complex and tightly regulated process ensures a continuous supply of oxygen-carrying red blood cells, maintaining normal blood oxygen levels and supporting overall bodily function.'
"
Protein | Definition | Taxonomy |
---|---|---|
40S ribosomal protein S6 | A small ribosomal subunit protein eS6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P62753] | Homo sapiens (human) |
B-cell lymphoma 6 protein | A B-cell lymphoma 6 protein that is encoded in the genome of human. [PRO:CNA, UniProtKB:P41182] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
amanozine | diamino-1,3,5-triazine | ||
rifamycin sv | rifamycin SV : A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. rifamycin SV: RN given refers to parent cpd; structure in Merck Index, 9th ed, #8009 | acetate ester; cyclic ketal; lactam; macrocycle; organic heterotetracyclic compound; polyphenol; rifamycins | antimicrobial agent; antitubercular agent; bacterial metabolite |
gentamicin sulfate | |||
pf-562,271 | indoles | ||
PF-06446846 | PF-06446846 : A triazolopyridine that is 3H-[1,2,3]triazolo[4,5-b]pyridine substituted by a 4-{(3-chloropyridin-2-yl)[(3R)-piperidin-3-yl]carbamoyl}phenyl group at position 3. It is a potent inhibitor of PCSK9. PF-06446846: inhibits translation of PCSK9 ;structure in first source | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor |